Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | THPO | P40225 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL44660 | 0.88 | — | — | |
| SCHEMBL21773361 | 0.78 | — | — | |
| SCHEMBL1274243 | 0.76 | ALDH1A1 (0.32) | ALDH1A1TSHR | |
| Ethaneperoxoic Acid SCHEMBL562267 | 0.74 | TSHR (0.55) | ALDH1A1TSHRTHPO | |
| Ethaneperoxoic Acid SCHEMBL4954376 | 0.74 | TSHR (0.55) | ALDH1A1TSHRTHPO | |
| Ethaneperoxoic Acid SCHEMBL6912 | 0.74 | — | — | |
| SCHEMBL53 | 0.74 | ALDH1A1 (0.50) | ALDH1A1TSHR | |
| SCHEMBL8650561 | 0.72 | ALDH1A1 (0.56) | ALDH1A1TSHR | |
| SCHEMBL8650562 | 0.72 | ALDH1A1 (0.56) | ALDH1A1TSHR | |
| Ethaneperoxoic Acid SCHEMBL11230331 | 0.72 | ALDH1A1 (0.33) | ALDH1A1TSHRTHPO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070105933-A1 | Amino alcohol compounds | SANKYO COMPANY, LIMITED (JP) | 2007-05-10 | — | — | US | disclosed |
| US-5220042-A | Antiasthmatics, antiallergens, cardiovasculsr disorders | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1993-06-15 | — | — | US | disclosed |
| EP-0151995-B1 | NOVEL 1,4-BENZOQUINONE DERIVATIVES AND BENZENE DERIVATIVES, AND PROCESS FOR PREPARING THE SAME | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1992-12-23 | — | — | EP | disclosed |
| US-5164410-A | Fumagillol derivatives and pharmaceutical compositions thereof | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1992-11-17 | — | — | US | disclosed |
| EP-0151995-A2 | Novel 1,4-benzoquinone derivatives and benzene derivatives, and process for preparing the same | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1985-08-21 | — | — | EP | disclosed |
| US-4046760-A | Process for preparing 1-α-hydroxy cholesterol derivatives | MERCK & CO., INC. (US) | 1977-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070105933-A1 | Amino alcohol compounds | ADH1C, C9, SSB | ALDH1A1 582/4885TSHR 238/4885THPO 2241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.